 |
|
| LUNG CANCER
| |
| | |
|
|
Dana-Farber Cancer Institute Handbook
To order this title, and for more information, click here
Edited By
Arthur Skarin, MD, FACP, FCCP, Associate Professor of Medicine, Harvard Medical School, Boston, MA, USA; Senior Attending Physician, Dana-Farber Cancer Institute, Boston, MA, USA
Paul Lorigan, MB, FRCP, Senior Lecturer in Medical Oncology, Christie Hospital NHS Trust, Manchester, UK
Included in series
Dana-Farber Cancer Institute Handbooks,
Description
Written by highly eminent authors, Lung Cancer - a handbook in the Dana-Farber Cancer Institute series - is produced in full color and
is richly illustrated throughout, providing a review of each cancer including its incidence, epidemiology, etiology and histopathology,
together with the clinical features. Diagnostic studies and current clinical and pathological staging are also given. Detailed tables
are provided with histopathological classification, diagnostic studies and, when important, prognostic factors. Current therapies are
also discussed in detail, particularly the management of metastatic lung disease in the context of new and emerging treatments.
Audience
The book is aimed at trainee oncologists and general physicians who manage cancer patients outside of specialist centers.
Contents
Introduction
The role of molecular probes and other markers in the diagnosis and characterization of malignancy
Lung cancer:
aetiology, histopathology and clinical manifestation
Lung cancer treatment
Systemic and mucocutaneous reactions to chemotherapy
| Bibliographic details |
Paperback, 168 pages, publication date: JUN-2007
ISBN-13: 978-0-7234-3437-5
ISBN-10: 0-7234-3437-9
Imprint: MOSBY
|
999/999
Last update: 25 Nov 2009
|
|
| |
| | |
|
|
| |
Home | Elsevier Sites | Privacy Policy | Terms and Conditions | Feedback | Site Map | A Reed Elsevier Company